Related case:
CAS 2017_A_5320 USADA vs Ryan Bailey
November 30, 2017
In January 2017 the United States Anti-Doping Agency (USADA) has reported an anti-doping rule violation against the bobsled Athlete Ryan Bailey after his sample tested positive for the prohibited substance 5-Methylhexan-2-amine (1,4-dimethylpentylamine, 1,4-dimethylamylamine, 1,4-DMAA). After notification a provisional suspension was ordered and the Athlete filed a statement with evidence in his defence.
In this case USADA accepted after the Athlete's prompt admission that the source of the Athlete’s positive test was the supplement “Weapon X”. Detailed analysis conducted on the supplement by the WADA-accredited laboratory in Salt Lake City confirmed that the supplement contained DMBA. Although DMBA was not listed on the Supplement Facts label, another closely related prohibited stimulant, methylhexaneamine, also known as 1,3-Dimethylamylamine (DMAA), was listed on the label.
As a result the current version of the supplement that caused the Athlete’s positive test, which lists DMAA as an ingredient, but in fact contains DMBA, was added in April 2017 to the USADA High Risk List of supplements maintained on USADA’s online dietary supplement safety education and awareness resource, Supplement 411.
The Panel of the American Arbitration Association (AAA) Commercial Arbitration Tribunal finds that the Athlete has sustained his burden of proof, by a balance of probability to qualify for a reduction on the Athlete’s period of ineligibility, based on his light degree of fault.
Therefore the AAA Commercial Arbitration Tribunal decides on 26 July 2017 to impose a 6 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 20 January 2017.
